1.57
-0.02(-1.26%)
Currency In USD
| Previous Close | 1.59 |
| Open | 1.56 |
| Day High | 1.57 |
| Day Low | 1.54 |
| 52-Week High | 2.55 |
| 52-Week Low | 1.03 |
| Volume | 26,744 |
| Average Volume | 131,339 |
| Market Cap | 11.74M |
| PE | -1.06 |
| EPS | -1.47 |
| Moving Average 50 Days | 1.74 |
| Moving Average 200 Days | 1.7 |
| Change | -0.02 |
If you invested $1000 in BioRestorative Therapies, Inc. (BRTX) 10 years ago, it would be worth $0.04 as of May 21, 2025 at a share price of $1.565. Whereas If you bought $1000 worth of BioRestorative Therapies, Inc. (BRTX) shares 5 years ago, it would be worth $3,912.5 as of May 21, 2025 at a share price of $1.565.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire Inc.
May 14, 2025 8:05 PM GMT
MELVILLE, N.Y., May 14, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial
Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
GlobeNewswire Inc.
May 13, 2025 1:15 PM GMT
MELVILLE, N.Y., May 13, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is please
BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
GlobeNewswire Inc.
May 08, 2025 8:30 PM GMT
MELVILLE, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today ann